lonafarnib has been researched along with okadaic acid in 1 studies
Studies (lonafarnib) | Trials (lonafarnib) | Recent Studies (post-2010) (lonafarnib) | Studies (okadaic acid) | Trials (okadaic acid) | Recent Studies (post-2010) (okadaic acid) |
---|---|---|---|---|---|
224 | 34 | 90 | 3,865 | 2 | 658 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, BB; Khuri, FR; Takada, Y | 1 |
1 other study(ies) available for lonafarnib and okadaic acid
Article | Year |
---|---|
Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis.
Topics: Active Transport, Cell Nucleus; Alkyl and Aryl Transferases; Apoptosis; Blotting, Western; Carcinogens; Cell Division; Cell Line, Tumor; Cell Survival; Cytoplasm; DNA; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; I-kappa B Kinase; Immunohistochemistry; In Situ Nick-End Labeling; Inflammation; Jurkat Cells; Models, Chemical; Neovascularization, Pathologic; NF-kappa B; Okadaic Acid; Phosphorylation; Piperidines; Protein Binding; Protein Serine-Threonine Kinases; Pyridines; ras Proteins; Smoking; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2004 |